These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 3102504
21. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts. Hayakawa Y, Tazawa S, Ishikawa T, Niiya K, Sakuragawa N. Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010 [Abstract] [Full Text] [Related]
29. Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation. Cohen RL, Niclas J, Lee WM, Wun TC, Crowley CW, Levinson AD, Sadler JE, Shuman MA. J Biol Chem; 1989 May 15; 264(14):8375-83. PubMed ID: 2498314 [Abstract] [Full Text] [Related]
30. Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis. Montemurro P, Barbuti G, Conese M, Gabriele S, Petio M, Colucci M, Semeraro N. Br J Haematol; 1999 Nov 15; 107(2):294-9. PubMed ID: 10583214 [Abstract] [Full Text] [Related]
31. Localization of urokinase-type plasminogen activator receptor on U937 cells: phorbol ester PMA induces heterogeneity. Hansen SH, Behrendt N, Danø K, Kristensen P. Exp Cell Res; 1990 Apr 15; 187(2):255-62. PubMed ID: 2156717 [Abstract] [Full Text] [Related]
32. The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity. Dear AE, Medcalf RL. Biochim Biophys Acta; 2000 Jun 21; 1492(1):15-22. PubMed ID: 11004477 [Abstract] [Full Text] [Related]
33. Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. Kruithof EK, Vassalli JD, Schleuning WD, Mattaliano RJ, Bachmann F. J Biol Chem; 1986 Aug 25; 261(24):11207-13. PubMed ID: 3090045 [Abstract] [Full Text] [Related]
37. Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Lacave R, Rondeau E, Ochi S, Delarue F, Schleuning WD, Sraer JD. Kidney Int; 1989 Mar 25; 35(3):806-11. PubMed ID: 2496257 [Abstract] [Full Text] [Related]
38. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1. Michel JB, Quertermous T. J Immunol; 1989 Aug 01; 143(3):890-5. PubMed ID: 2501387 [Abstract] [Full Text] [Related]
39. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. Gelehrter TD, Sznycer-Laszuk R. J Clin Invest; 1986 Jan 01; 77(1):165-9. PubMed ID: 2418059 [Abstract] [Full Text] [Related]
40. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. Quax PH, van Muijen GN, Weening-Verhoeff EJ, Lund LR, Danø K, Ruiter DJ, Verheijen JH. J Cell Biol; 1991 Oct 01; 115(1):191-9. PubMed ID: 1918136 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]